Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafaa Wahab

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Lung|February 22, 2023
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional SurveyElena Kum, Danica Brister, Nermin Diab, et al.
Chest|May 15, 2026
Moving Beyond Responders: A post-hoc Analysis Identifying Criteria for Chronic Cough ControlMustafaa Wahab, Elena Kum, Nermin Diab, et al.
The European Respiratory Journal|November 6, 2025
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trialNermin Diab, Danica Brister, Elena Kum, et al.
The European Respiratory Journal|May 7, 2026
Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxinChristiane Whetstone, Nermin Diab, Danica Brister, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Lung|February 22, 2023
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional SurveyElena Kum, Danica Brister, Nermin Diab, et al.
Chest|May 15, 2026
Moving Beyond Responders: A post-hoc Analysis Identifying Criteria for Chronic Cough ControlMustafaa Wahab, Elena Kum, Nermin Diab, et al.
The European Respiratory Journal|November 6, 2025
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trialNermin Diab, Danica Brister, Elena Kum, et al.
The European Respiratory Journal|May 7, 2026
Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxinChristiane Whetstone, Nermin Diab, Danica Brister, et al.
Pageof 2